Lab News

July 2018 Ben Engebretson presented a poster of his summer research project "Validating Ephrin B1 binding partners" at the SD Undergraduate Research Symposium in Pierre, SD. Ben is a student at Northwestern University who spent the summer in the Vermeer Lab.

June 2018 Paola Vermeer received a research grant from the Sanford Foundation to test the therapeutic efficacy of anti-Ephrin B1 antibodies in head & neck cancer. “Using Ephrin B1 antibodies to attenuate tumor innervation in head and neck squamous cell carcinoma".

April 2018 Paola Vermeer, Sam Milanovich and Alexei Savinov co-authored a research poster presented at the American Association for Cancer Research annual meeting in Chicago. This meeting covers the latest basic, translational, clinical and prevention-focused cancer research including areas such as early detection, cancer interception and survivorship. Dr. Milanovich presented the poster titled “Single nucleotide variations within and around microRNA-binding sites”. 

March 2018 Chris Lucido, MD-PhD student in the Vermeer Lab, was awarded the Graduate Research and Creative Scholarship Grant from the University of South Dakota. The award provides funds to cover the cost of supplies, books and travel as well as other costs to support his project. He presented his project titled "Defining the Contribution of Tumor Innervation to Treatment Resistance" at the annual IdeaFest.

February 2018 Dr. Paola Vermeer co-authored a manuscript in Cancer Research investigating if the pro-inflammatory cytokine interleukin-1 mediates cancer-related fatigue. "Tumor-associated fatigue in cancer patients develops independently of interleukin-1 signaling"   

November 2017 USD SSOM MD-PhD graduate student Christopher Lucido was invited to give an oral presentation at the annual meeting of the American Medical Association on his research in the Vermeer laboratory and received the award for the best medical student presentation. His talk was titled "Utilization of β-blockers in the treatment of HPV(+) head and neck squamous cell carcinoma”.

February 2017 Paola Vermeer, PhD, recently gave an invited seminar to students and faculty in the Biomedical Engineering Department at the University of South Dakota titled "Generating a non-oncogenic yet antigenic vaccine for HPV16-positive head and neck squamous cell carcinoma".